The US is ready to vaccinate children from 5-11 years old

On October 20, the White House announced that the US is ready to launch a COVID-19 vaccination program for children aged 5-11 next month, according to which 28 million more people will be eligible for vaccination.

A 16-year-old boy receives a Pfizer/BioNTech COVID-19 vaccine in Worcester, Massachusetts, USA. Photo: AFP
A 16-year-old boy receives a Pfizer/BioNTech COVID-19 vaccine in Worcester, Massachusetts, USA. Photo: AFP

The White House announcement stated that the government was prepared to be ready to deploy vaccination immediately after the Centers for Disease Control and Prevention (CDC) made recommendations for vaccination for children aged 5-11. Accordingly, the government has directed the establishment of vaccination points in more than 100 children's hospital systems nationwide, as well as clinics, pharmacies and schools.

The White House said the plan will help the US quickly deploy vaccine distribution and ensure that the vaccine is available to every household across the country as soon as Pfizer's vaccine is approved for use in young children.

Speaking on NBC News, US Surgeon General Vivek Murthy emphasized that careful preparation helps to deploy vaccination quickly and helps ensure proactive supply of vaccines to all vaccination sites when there is a need.

Earlier, earlier this month, pharmaceutical company Pfizer applied for a license to use a COVID-19 vaccine, jointly developed by it and its partner BioNTech (Germany), for children aged 5-11 years old in the US. The US regulatory agencies have appointed two expert committees to discuss and make decisions on licensing, in which, the committee convened by the US Food and Drug Administration (FDA) will meet. next week and the remaining committee appointed by the CDC will conduct discussions in early November. It is expected that these two committees will quickly reach a conclusion after the meetings.

In the clinical trial, a group of children aged 5-11 years received two doses of Pfizer/BioNTech's vaccine at a dose of 10 micrograms, lower than the 30 micrograms for the older age group. Two injections 21 days apart.

Pfizer/BioNTech's vaccine has been officially approved by the FDA for children 16 years of age and older, and in May, the FDA also approved emergency use of this vaccine for children aged 12-15.

Experts recommend that childhood vaccination is a necessary condition for herd immunity against COVID-19. Although young children are less likely to get worse, they can still catch the disease and pass it on to others.

As of October 20, about 77.1% of people 12 years of age and older in the United States had received at least one dose of the vaccine.

Google Tech News

Post a Comment

Previous Post Next Post